Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis

被引:2
|
作者
Ardizzoia, Federica [1 ,2 ,4 ]
Lorentino, Francesca [1 ,2 ,3 ]
Bruno, Alessandro [1 ]
Marktel, Sarah [1 ]
Giglio, Fabio [1 ]
Clerici, Daniela [1 ]
Farina, Francesca [1 ]
Mastaglio, Sara [1 ]
Piemontese, Simona [1 ]
Assanelli, Andrea A. [1 ]
Carrabba, Matteo G. [1 ]
Bernardi, Massimo [1 ]
Corti, Consuelo [1 ]
Peccatori, Jacopo [1 ]
Ciceri, Fabio [1 ,2 ]
Greco, Raffaella [1 ]
Lupo-Stanghellini, Maria Teresa [1 ]
机构
[1] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
[3] Univ Milano Bicocca, Dept Med & Surg, PhD Program Publ Hlth, Milan, Italy
[4] Univ Bologna, IRCCS Azienda Osped Univ Bologna Policlin St Orso, Ist Ematol & Oncol Medica LeA Seragnoli, Alma Mater Studiorum, Bologna, Italy
关键词
ACUTE GVHD;
D O I
10.3324/haematol.2022.281269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2748 / 2751
页数:4
相关论文
共 50 条
  • [1] Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
    Ardizzoia, Federica
    Lorentino, Francesca
    Bruno, Alessandro
    Marktel, Sarah
    Giglio, Fabio
    Clerici, Daniela
    Farina, Francesca
    Mastaglio, Sara
    Piemontese, Simona
    Assanelli, Andrea A.
    Carrabba, Matteo G.
    Bernardi, Massimo
    Corti, Consuelo
    Peccatori, Jacopo
    Ciceri, Fabio
    Greco, Raffaella
    Lupo-Stanghellini, Maria Teresa
    HAEMATOLOGICA, 2022, 107 : 2748 - 2751
  • [2] Predictors of Graft-Versus-Host Disease with Post-Transplant Cyclophosphamide
    Saliba, Rima M.
    Aljawai, Yosra M.
    Alousi, Amin M.
    Oran, Betul
    Popat, Uday
    Champlin, Richard E.
    Shpall, Elizabeth J.
    BLOOD, 2024, 144 : 4890 - 4891
  • [3] Validation of Minnesota acute graft-versus-host disease Risk Score
    MacMillan, Margaret L.
    DeFor, Todd E.
    Holtan, Shernan G.
    Rashidi, Armin
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    HAEMATOLOGICA, 2020, 105 (02) : 519 - 524
  • [4] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
    Ruggeri, Annalisa
    Sun, Yuqian
    Labopin, Myriam
    Bacigalupo, Andrea
    Lorentino, Francesca
    Arcese, William
    Santarone, Stella
    Gulbas, Zafer
    Blaise, Didier
    Messina, Giuseppe
    Ghavamzadeh, Ardeshi
    Malard, Florent
    Bruno, Benedetto
    Diez-Martin, Jose Luis
    Koc, Yener
    Ciceri, Fabio
    Mohty, Mohamad
    Nagler, Arnon
    HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
  • [5] Post-transplant damage: chronic graft-versus-host disease
    Munoz Montano, M. R.
    Duran Sanchez, I. M.
    Torres Munoz, R. M.
    Jimenez Martinez, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S343 - S343
  • [6] Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies
    Dulery, Remy
    Brissot, Eolia
    Mohty, Mohamad
    BLOOD REVIEWS, 2023, 62
  • [7] Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell
    Koh, Jeong Suk
    Heo, Buyeon
    Lee, Seul Bi
    Choi, Su-Young
    Pham, Thi Thuy Duong
    Lee, Sang-Woo
    Park, Jung-Hyun
    Jang, Yunseon
    Seo, Wonhyoung
    Lee, Myung-Won
    Jo, Deog-Yeon
    Kwon, Jaeyul
    Song, Ik Chan
    BLOOD, 2024, 144 : 7371 - 7371
  • [8] Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease
    Al-Homsi, Ahmad Samer
    Roy, Tara S.
    Cole, Kelli
    Feng, Yuxin
    Duffner, Ulrich
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (04) : 604 - 611
  • [9] Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease
    S Kumar
    MG Chen
    DA Gastineau
    MA Gertz
    DJ Inwards
    MQ Lacy
    A Tefferi
    WS Harmsen
    MR Litzow
    Bone Marrow Transplantation, 2001, 27 : 1133 - 1140
  • [10] Post-transplant graft-versus-host lymphadenopathy
    Nodit, L
    Murase, N
    Reyes, JD
    Mazariegos, GV
    Sindhi, R
    Jaffe, R
    LABORATORY INVESTIGATION, 2004, 84 (02) : 272 - 272